Alnylam to webcast presentation at 42nd annual j.p. morgan healthcare conference

Cambridge, mass.--(business wire)--alnylam pharmaceuticals, inc. (nasdaq: alny), the leading rnai therapeutics company, announced today that management will present a company overview and participate in a q&a session at the 42nd annual j.p. morgan healthcare conference on monday, january 8, 2024 at 9:45 am pt (12:45 pm et) at the westin st. francis in san francisco. this presentation will include an update on unaudited fourth quarter and full year 2023 global net product revenues. a live au.
ALNY Ratings Summary
ALNY Quant Ranking